Anúncio
Anúncio

CRMD

CRMD logo

CorMedix Inc.

7.63
USD
Patrocinado
+0.12
+1.57%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

7.63

0.00
-0.04%

Relatórios de Lucros CRMD

Rácio de surpresa positiva

CRMD separação 25 de 40 últimas estimativas.

63%

Próximo Relatório

Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$130.07M
/
$0.85
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+24.74%
/
-32.54%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+316.78%
/
+286.36%

CorMedix Inc. earnings per share and revenue

On 12 de nov. de 2025, CRMD reported earnings of 1.26 USD per share (EPS) for Q3 25, beating the estimate of 0.65 USD, resulting in a 91.46% surprise. Revenue reached 104.28 milhão, compared to an expected 87.74 milhão, with a 18.84% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of 0.85 USD, with revenue projected to reach 130.07 milhão USD, implying an diminuir of -32.54% EPS, and aumentar of 24.74% in Revenue from the last quarter.
FAQ
For Q3 2025, CorMedix Inc. reported EPS of $1.26, beating estimates by 91.46%, and revenue of $104.28M, 18.84% above expectations.
The stock price moved up 2.06%, changed from $11.19 before the earnings release to $11.42 the day after.
The next earning report is scheduled for 23 de mar. de 2026.
Based on 9 analistas, CorMedix Inc. is expected to report EPS of $0.85 and revenue of $130.07M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio